ORIC Pharmaceuticals Inc. (ORIC) NASDAQ
$9.23 (0.08) (-0.86%)
Market Cap: $627.70M
As of 05/16/24 01:21 PM EDT. Market open.
ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ
$9.23
(0.08) (-0.86%)
Market Cap: $627.70M
As of 05/16/24 01:21 PM EDT. Market open.
Add to Portfolio
oric pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. its lead product candidate is oric-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. the company's second product candidate is oric-533, an ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jacob Chacko
Full Time Employees
86
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jacob Chacko
Full Time Employees
86
Address
240 E. Grand Ave., 2Nd Floor, California, South San Francisco, 94080.
PRICE CHART FOR ORIC PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.16
Previous Close
$9.31
Days Range
$8.84 - $9.78
52 week range
$4.91 - $16.65
Volume
92,654
Avg. Volume (30 days)
439,962
Market Cap
$627.70M
Dividend Yield
-
P/E
-
Shares Outstanding
67,422,307
Open
$9.16
Previous Close
$9.31
Days Range
$8.84 - $9.78
52 week range
$4.91 - $16.65
Volume
92,654
Avg. Volume (30 days)
439,962
Market Cap
$627.70M
Dividend Yield
-
P/E
-
Shares Outstanding
67,422,307
FINANCIAL STATEMENTS FOR ORIC PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR ORIC PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Chacko Jacob | PRESIDENT AND CEO | Mar 06, 2024 | Sale | $16.21 | 40,000 | 648,380 | 728,544 | Mar 08, 2024, 04:20 PM |
Chacko Jacob | PRESIDENT AND CEO | Feb 07, 2024 | Sale | $12.30 | 26,042 | 320,186 | 768,544 | Feb 08, 2024, 08:01 PM |
Chacko Jacob | PRESIDENT AND CEO | Feb 06, 2024 | Sale | $12.12 | 13,958 | 169,160 | 794,586 | Feb 08, 2024, 08:01 PM |
Multani Pratik S | Chief Medical Officer | Dec 15, 2023 | Sale | $8.59 | 5,282 | 45,351 | 23,809 | Dec 19, 2023, 07:42 PM |
Piscitelli Dominic | Chief Financial Officer | Dec 15, 2023 | Sale | $8.58 | 5,282 | 45,338 | 83,809 | Dec 19, 2023, 07:40 PM |
Chacko Jacob | President and CEO | Dec 15, 2023 | Sale | $8.58 | 14,539 | 124,813 | 808,544 | Dec 19, 2023, 07:39 PM |
Chacko Jacob | President and CEO | Jul 11, 2023 | Sale | $8.01 | 5,156 | 41,287 | 780,652 | Jul 11, 2023, 09:28 PM |
Chacko Jacob | President and CEO | Jul 10, 2023 | Sale | $8.01 | 10,508 | 84,212 | 785,808 | Jul 11, 2023, 09:28 PM |
Chacko Jacob | President and CEO | Jul 05, 2023 | Sale | $8.01 | 4,336 | 34,711 | 796,316 | Jul 07, 2023, 04:35 PM |
Chacko Jacob | President and CEO | Jun 26, 2023 | Sale | $8.03 | 20,000 | 160,562 | 800,652 | Jun 28, 2023, 07:18 PM |
Multani Pratik S | Chief Medical Officer | Dec 15, 2022 | Sale | $3.07 | 2,227 | 6,846 | 7,285 | Feb 17, 2023, 04:25 PM |
Piscitelli Dominic | Chief Financial Officer | Dec 15, 2022 | Sale | $3.08 | 2,227 | 6,854 | 67,285 | Feb 17, 2023, 04:23 PM |
Chacko Jacob | President and CEO | Dec 15, 2022 | Sale | $3.07 | 6,137 | 18,859 | 816,652 | Feb 17, 2023, 04:22 PM |
Multani Pratik S | Chief Medical Officer | Dec 15, 2022 | Sale | $3.25 | 2,089 | 6,789 | 7,423 | Dec 16, 2022, 08:51 PM |
Piscitelli Dominic | Chief Financial Officer | Dec 15, 2022 | Sale | $3.25 | 2,089 | 6,789 | 67,423 | Dec 16, 2022, 08:49 PM |
Chacko Jacob | President and CEO | Dec 15, 2022 | Sale | $3.25 | 5,764 | 18,733 | 817,025 | Dec 16, 2022, 08:47 PM |
Chacko Jacob | President and CEO | May 13, 2022 | Buy | $2.82 | 76,072 | 214,561 | 802,652 | May 13, 2022, 06:52 PM |
Chacko Jacob | President and CEO | May 12, 2022 | Buy | $2.75 | 69,354 | 190,467 | 726,580 | May 13, 2022, 06:52 PM |
Chacko Jacob | President and CEO | May 11, 2022 | Buy | $2.90 | 304,574 | 883,569 | 657,226 | May 13, 2022, 06:52 PM |
Piscitelli Dominic | Chief Financial Officer | Mar 31, 2022 | Buy | $5.36 | 60,000 | 321,624 | 60,000 | Mar 31, 2022, 08:51 PM |
Chacko Jacob | President and CEO | Mar 25, 2022 | Buy | $4.54 | 50,000 | 227,170 | 352,652 | Mar 25, 2022, 06:42 PM |
Chacko Jacob | President and CEO | Mar 24, 2022 | Buy | $5.03 | 42,873 | 215,660 | 302,652 | Mar 25, 2022, 06:42 PM |
Chacko Jacob | President and CEO | Mar 23, 2022 | Buy | $4.98 | 257,127 | 1,280,878 | 259,779 | Mar 25, 2022, 06:42 PM |
COLUMN GROUP II, LP | 10% Owner | Nov 12, 2021 | Option Exercise | $16.00 | 16,625 | 266,000 | 16,625 | Nov 16, 2021, 04:49 PM |
Heyman Richard A. | Director | Sep 14, 2021 | Sale | $25.05 | 706 | 17,686 | 216,954 | Sep 16, 2021, 06:19 PM |
Heyman Richard A. | Director | Sep 15, 2021 | Sale | $25.03 | 682 | 17,074 | 216,272 | Sep 16, 2021, 06:19 PM |
Chacko Jacob | President and CEO | Sep 15, 2021 | Sale | $25.06 | 3,736 | 93,629 | 2,652 | Sep 16, 2021, 06:17 PM |
Chacko Jacob | President and CEO | Sep 14, 2021 | Sale | $25.05 | 4,420 | 110,706 | 6,388 | Sep 16, 2021, 06:17 PM |
Heyman Richard A. | Director | Sep 13, 2021 | Sale | $25.01 | 601 | 15,033 | 217,660 | Sep 14, 2021, 04:03 PM |
Heyman Richard A. | Director | Sep 10, 2021 | Sale | $25.10 | 479 | 12,023 | 218,261 | Sep 14, 2021, 04:03 PM |
Chacko Jacob | President and CEO | Sep 13, 2021 | Sale | $25.02 | 2,801 | 70,089 | 10,808 | Sep 14, 2021, 04:01 PM |
Chacko Jacob | President and CEO | Sep 10, 2021 | Sale | $25.08 | 2,942 | 73,783 | 13,609 | Sep 14, 2021, 04:01 PM |
Heyman Richard A. | Director | Sep 07, 2021 | Sale | $25.11 | 1,086 | 27,272 | 218,740 | Sep 09, 2021, 04:36 PM |
Chacko Jacob | President and CEO | Sep 08, 2021 | Sale | $25.03 | 200 | 5,007 | 16,551 | Sep 09, 2021, 04:33 PM |
Chacko Jacob | President and CEO | Sep 07, 2021 | Sale | $25.11 | 5,981 | 150,173 | 16,751 | Sep 09, 2021, 04:33 PM |
SCHELLER RICHARD H | Director | May 24, 2021 | Sale | $25.00 | 100 | 2,500 | 39,092 | May 24, 2021, 07:29 PM |
SCHELLER RICHARD H | Director | May 21, 2021 | Sale | $25.19 | 1,231 | 31,008 | 39,192 | May 24, 2021, 07:29 PM |
SCHELLER RICHARD H | Director | May 20, 2021 | Sale | $25.08 | 659 | 16,528 | 40,423 | May 24, 2021, 07:29 PM |
Heyman Richard A. | Director | May 18, 2021 | Sale | $25.32 | 2,161 | 54,715 | 221,226 | May 18, 2021, 08:22 PM |
Heyman Richard A. | Director | May 17, 2021 | Sale | $25.07 | 498 | 12,484 | 223,387 | May 18, 2021, 08:22 PM |
Heyman Richard A. | Director | May 14, 2021 | Sale | $25.31 | 3,215 | 81,382 | 223,885 | May 18, 2021, 08:22 PM |
SCHELLER RICHARD H | Director | May 18, 2021 | Sale | $25.34 | 2,800 | 70,958 | 41,082 | May 18, 2021, 08:20 PM |
SCHELLER RICHARD H | Director | May 17, 2021 | Sale | $25.06 | 500 | 12,530 | 43,882 | May 18, 2021, 08:20 PM |
SCHELLER RICHARD H | Director | May 14, 2021 | Sale | $25.38 | 4,615 | 117,117 | 44,382 | May 18, 2021, 08:20 PM |
Heyman Richard A. | Director | Apr 30, 2021 | Sale | $25.26 | 100 | 2,526 | 227,200 | Apr 30, 2021, 07:59 PM |
Heyman Richard A. | Director | Apr 28, 2021 | Sale | $25.08 | 100 | 2,508 | 227,300 | Apr 30, 2021, 07:59 PM |
Heyman Richard A. | Director | Apr 01, 2021 | Sale | $25.00 | 100 | 2,500 | 227,400 | Apr 05, 2021, 07:42 PM |
Chacko Jacob | President and CEO | Apr 01, 2021 | Sale | $25.09 | 800 | 20,070 | 61,700 | Apr 05, 2021, 07:40 PM |
GORDON CARL L | Director | Mar 30, 2021 | Sale | $23.93 | 27,869 | 666,905 | 2,212,571 | Mar 31, 2021, 05:11 PM |
GORDON CARL L | Director | Mar 29, 2021 | Sale | $23.31 | 75,555 | 1,761,187 | 2,240,440 | Mar 31, 2021, 05:11 PM |
ORBIMED ADVISORS LLC | Director | Mar 29, 2021 | Sale | $23.31 | 75,555 | 1,761,187 | 2,240,440 | Mar 31, 2021, 05:08 PM |
ORBIMED ADVISORS LLC | Director | Mar 30, 2021 | Sale | $23.93 | 27,869 | 666,905 | 2,212,571 | Mar 31, 2021, 05:08 PM |
ORBIMED ADVISORS LLC | Director | Mar 26, 2021 | Sale | $23.88 | 27,816 | 664,246 | 2,315,995 | Mar 26, 2021, 05:51 PM |
ORBIMED ADVISORS LLC | Director | Mar 25, 2021 | Sale | $24.70 | 51,523 | 1,272,618 | 2,343,811 | Mar 26, 2021, 05:51 PM |
ORBIMED ADVISORS LLC | Director | Mar 24, 2021 | Sale | $24.80 | 32,959 | 817,383 | 2,395,334 | Mar 26, 2021, 05:51 PM |
GORDON CARL L | Director | Mar 24, 2021 | Sale | $24.80 | 32,959 | 817,383 | 2,395,334 | Mar 26, 2021, 05:46 PM |
GORDON CARL L | Director | Mar 26, 2021 | Sale | $23.88 | 27,816 | 664,246 | 2,315,995 | Mar 26, 2021, 05:46 PM |
GORDON CARL L | Director | Mar 25, 2021 | Sale | $24.70 | 51,523 | 1,272,618 | 2,343,811 | Mar 26, 2021, 05:46 PM |
GORDON CARL L | Director | Mar 23, 2021 | Sale | $24.32 | 3,992 | 97,085 | 2,428,293 | Mar 23, 2021, 05:26 PM |
GORDON CARL L | Director | Mar 22, 2021 | Sale | $26.47 | 7,673 | 203,104 | 2,432,285 | Mar 23, 2021, 05:26 PM |
GORDON CARL L | Director | Mar 19, 2021 | Sale | $26.47 | 21,275 | 563,149 | 2,439,958 | Mar 23, 2021, 05:26 PM |
ORBIMED ADVISORS LLC | Director | Mar 23, 2021 | Sale | $24.32 | 3,992 | 97,085 | 2,428,293 | Mar 23, 2021, 05:22 PM |
ORBIMED ADVISORS LLC | Director | Mar 22, 2021 | Sale | $26.47 | 7,673 | 203,104 | 2,432,285 | Mar 23, 2021, 05:22 PM |
ORBIMED ADVISORS LLC | Director | Mar 19, 2021 | Sale | $26.47 | 21,275 | 563,149 | 2,439,958 | Mar 23, 2021, 05:22 PM |
ORBIMED ADVISORS LLC | Director | Mar 18, 2021 | Sale | $28.03 | 6,059 | 169,834 | 2,461,233 | Mar 18, 2021, 09:07 PM |
ORBIMED ADVISORS LLC | Director | Mar 17, 2021 | Sale | $28.43 | 18,790 | 534,200 | 2,467,292 | Mar 18, 2021, 09:07 PM |
ORBIMED ADVISORS LLC | Director | Mar 16, 2021 | Sale | $27.72 | 41,353 | 1,146,305 | 2,486,082 | Mar 18, 2021, 09:07 PM |
GORDON CARL L | Director | Mar 18, 2021 | Sale | $28.03 | 6,059 | 169,834 | 2,461,233 | Mar 18, 2021, 09:04 PM |
GORDON CARL L | Director | Mar 17, 2021 | Sale | $28.43 | 18,790 | 534,200 | 2,467,292 | Mar 18, 2021, 09:04 PM |
GORDON CARL L | Director | Mar 16, 2021 | Sale | $27.72 | 41,353 | 1,146,305 | 2,486,082 | Mar 18, 2021, 09:04 PM |
ORBIMED ADVISORS LLC | Director | Mar 15, 2021 | Sale | $29.14 | 89,210 | 2,599,579 | 2,527,435 | Mar 15, 2021, 08:55 PM |
ORBIMED ADVISORS LLC | Director | Mar 12, 2021 | Sale | $30.29 | 90,521 | 2,741,881 | 2,616,645 | Mar 15, 2021, 08:55 PM |
ORBIMED ADVISORS LLC | Director | Mar 11, 2021 | Sale | $33.04 | 58,551 | 1,934,525 | 2,707,166 | Mar 15, 2021, 08:55 PM |
GORDON CARL L | Director | Mar 15, 2021 | Sale | $29.14 | 89,210 | 2,599,579 | 2,527,435 | Mar 15, 2021, 08:50 PM |
GORDON CARL L | Director | Mar 12, 2021 | Sale | $30.29 | 90,521 | 2,741,881 | 2,616,645 | Mar 15, 2021, 08:50 PM |
GORDON CARL L | Director | Mar 11, 2021 | Sale | $33.04 | 58,551 | 1,934,525 | 2,707,166 | Mar 15, 2021, 08:50 PM |
ORBIMED ADVISORS LLC | Director | Apr 24, 2020 | Buy | $16.00 | 281,250 | 4,500,000 | 281,250 | Apr 28, 2020, 05:13 PM |
GORDON CARL L | Director | Apr 24, 2020 | Buy | $16.00 | 281,250 | 4,500,000 | 281,250 | Apr 28, 2020, 05:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Chacko Jacob | PRESIDENT AND CEO | 03/06/2024 | 648,380 |
Chacko Jacob | PRESIDENT AND CEO | 02/07/2024 | 320,186 |
Chacko Jacob | PRESIDENT AND CEO | 02/06/2024 | 169,160 |
Multani Pratik S | Chief Medical Officer | 12/15/2023 | 45,351 |
Piscitelli Dominic | Chief Financial Officer | 12/15/2023 | 45,338 |
Chacko Jacob | President and CEO | 12/15/2023 | 124,813 |
Chacko Jacob | President and CEO | 07/11/2023 | 41,287 |
Chacko Jacob | President and CEO | 07/10/2023 | 84,212 |
Chacko Jacob | President and CEO | 07/05/2023 | 34,711 |
Chacko Jacob | President and CEO | 06/26/2023 | 160,562 |
Multani Pratik S | Chief Medical Officer | 12/15/2022 | 6,846 |
Piscitelli Dominic | Chief Financial Officer | 12/15/2022 | 6,854 |
Chacko Jacob | President and CEO | 12/15/2022 | 18,859 |
Multani Pratik S | Chief Medical Officer | 12/15/2022 | 6,789 |
Piscitelli Dominic | Chief Financial Officer | 12/15/2022 | 6,789 |
Chacko Jacob | President and CEO | 12/15/2022 | 18,733 |
Chacko Jacob | President and CEO | 05/13/2022 | 214,561 |
Chacko Jacob | President and CEO | 05/12/2022 | 190,467 |
Chacko Jacob | President and CEO | 05/11/2022 | 883,569 |
Piscitelli Dominic | Chief Financial Officer | 03/31/2022 | 321,624 |
Chacko Jacob | President and CEO | 03/25/2022 | 227,170 |
Chacko Jacob | President and CEO | 03/24/2022 | 215,660 |
Chacko Jacob | President and CEO | 03/23/2022 | 1,280,878 |
COLUMN GROUP II, LP | 10% Owner | 11/12/2021 | 266,000 |
Heyman Richard A. | Director | 09/14/2021 | 17,686 |
Heyman Richard A. | Director | 09/15/2021 | 17,074 |
Chacko Jacob | President and CEO | 09/15/2021 | 93,629 |
Chacko Jacob | President and CEO | 09/14/2021 | 110,706 |
Heyman Richard A. | Director | 09/13/2021 | 15,033 |
Heyman Richard A. | Director | 09/10/2021 | 12,023 |
Chacko Jacob | President and CEO | 09/13/2021 | 70,089 |
Chacko Jacob | President and CEO | 09/10/2021 | 73,783 |
Heyman Richard A. | Director | 09/07/2021 | 27,272 |
Chacko Jacob | President and CEO | 09/08/2021 | 5,007 |
Chacko Jacob | President and CEO | 09/07/2021 | 150,173 |
SCHELLER RICHARD H | Director | 05/24/2021 | 2,500 |
SCHELLER RICHARD H | Director | 05/21/2021 | 31,008 |
SCHELLER RICHARD H | Director | 05/20/2021 | 16,528 |
Heyman Richard A. | Director | 05/18/2021 | 54,715 |
Heyman Richard A. | Director | 05/17/2021 | 12,484 |
Heyman Richard A. | Director | 05/14/2021 | 81,382 |
SCHELLER RICHARD H | Director | 05/18/2021 | 70,958 |
SCHELLER RICHARD H | Director | 05/17/2021 | 12,530 |
SCHELLER RICHARD H | Director | 05/14/2021 | 117,117 |
Heyman Richard A. | Director | 04/30/2021 | 2,526 |
Heyman Richard A. | Director | 04/28/2021 | 2,508 |
Heyman Richard A. | Director | 04/01/2021 | 2,500 |
Chacko Jacob | President and CEO | 04/01/2021 | 20,070 |
GORDON CARL L | Director | 03/30/2021 | 666,905 |
GORDON CARL L | Director | 03/29/2021 | 1,761,187 |
ORBIMED ADVISORS LLC | Director | 03/29/2021 | 1,761,187 |
ORBIMED ADVISORS LLC | Director | 03/30/2021 | 666,905 |
ORBIMED ADVISORS LLC | Director | 03/26/2021 | 664,246 |
ORBIMED ADVISORS LLC | Director | 03/25/2021 | 1,272,618 |
ORBIMED ADVISORS LLC | Director | 03/24/2021 | 817,383 |
GORDON CARL L | Director | 03/24/2021 | 817,383 |
GORDON CARL L | Director | 03/26/2021 | 664,246 |
GORDON CARL L | Director | 03/25/2021 | 1,272,618 |
GORDON CARL L | Director | 03/23/2021 | 97,085 |
GORDON CARL L | Director | 03/22/2021 | 203,104 |
GORDON CARL L | Director | 03/19/2021 | 563,149 |
ORBIMED ADVISORS LLC | Director | 03/23/2021 | 97,085 |
ORBIMED ADVISORS LLC | Director | 03/22/2021 | 203,104 |
ORBIMED ADVISORS LLC | Director | 03/19/2021 | 563,149 |
ORBIMED ADVISORS LLC | Director | 03/18/2021 | 169,834 |
ORBIMED ADVISORS LLC | Director | 03/17/2021 | 534,200 |
ORBIMED ADVISORS LLC | Director | 03/16/2021 | 1,146,305 |
GORDON CARL L | Director | 03/18/2021 | 169,834 |
GORDON CARL L | Director | 03/17/2021 | 534,200 |
GORDON CARL L | Director | 03/16/2021 | 1,146,305 |
ORBIMED ADVISORS LLC | Director | 03/15/2021 | 2,599,579 |
ORBIMED ADVISORS LLC | Director | 03/12/2021 | 2,741,881 |
ORBIMED ADVISORS LLC | Director | 03/11/2021 | 1,934,525 |
GORDON CARL L | Director | 03/15/2021 | 2,599,579 |
GORDON CARL L | Director | 03/12/2021 | 2,741,881 |
GORDON CARL L | Director | 03/11/2021 | 1,934,525 |
ORBIMED ADVISORS LLC | Director | 04/24/2020 | 4,500,000 |
GORDON CARL L | Director | 04/24/2020 | 4,500,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ORIC PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
VIKING GLOBAL INVESTORS LP | 4,000,000 | 0.2% | New | Growth At A Reasonable Price |
BLACKROCK INC. | 3,178,185 | 0.00102% | 2.67% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,030,400 | 0.03% | New | Other |
GEODE CAPITAL MANAGEMENT, LLC | 911,633 | 0.00116% | 4.2% | Other |
VIVO CAPITAL, LLC | 849,681 | 0.92% | No change | Other |
ORBIMED ADVISORS LLC | 287,100 | 0.07% | -45.1% | Other |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 92,366 | 0.09% | -64.87% | Value |
RENAISSANCE TECHNOLOGIES LLC | 110,900 | 0.0024% | -41.17% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,943 | 0.02% | No change | Growth |
D. E. SHAW & CO., INC. | 98,433 | 0.00079% | Exited | Other |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 80,000 (Call) | 0.00358% | New | Value |
TUDOR INVESTMENT CORP ET AL | 29,205 | 0.00255% | New | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 14,298 | 0.00033% | 1.07% | Other |
CHANGE IN SHARES OUTSTANDING FOR ORIC PHARMACEUTICALS INC
STOCK BUYBACKS FOR ORIC PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
17.07%
1Q
09/30/2023
17.33%
2Q
03/31/2023
49.37%
4Q
12/31/2022
67.83%
5Q
09/30/2022
70.18%
6Q
06/30/2022
70.58%
7Q
03/31/2022
70.80%
8Q
12/31/2021
70.93%
9Q
09/30/2021
72.66%
10Q
06/30/2021
83.50%
11Q
03/31/2021
83.62%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ORIC PHARMACEUTICALS INC
LOADING...